Dysautonomia in Patients Post COVID-19 Infection
NCT04716465 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-01-22
Summary
The aim for this study is further to elucidate the presence of dysautonomia in post-covid-19 patients, by evaluating heart rate variability.
Conditions
- Covid19
Interventions
- OTHER
-
Dysautonomia
Indicators of dysautonomia
Sponsors & Collaborators
-
Moens Maarten
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-19
- Primary Completion
- 2023-01-31
- Completion
- 2023-01-31
Countries
- Belgium
Study Locations
More Related Trials
-
Transplanted-like Heart in Critical Ill Patients
NCT01930669 ·Status: COMPLETED ·Phase: NA
-
2019-nCoV Outbreak and Cardiovascular Diseases
NCT04255940 ·Status: UNKNOWN
-
Cardiovascular and Cerebrovascular Control in Healthy Subjects
NCT05706532 ·Status: RECRUITING
-
A Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Healthy Volunteers
NCT01643889 ·Status: COMPLETED ·Phase: PHASE1
-
Anxiety and Cardiovascular Autonomic Control
NCT00005471 ·Status: COMPLETED
-
Intravenous Beta-blockade for Improvement of Autonomic Activity
NCT00700466 ·Status: COMPLETED
-
Clinical Autonomic Disorders: A Training Protocol
NCT02154009 ·Status: TERMINATED
-
Study of Atenolol Influence on Blood Pressure During Resistance Exercise
NCT01030016 ·Status: COMPLETED ·Phase: PHASE4
-
Beta2-adrenergic System and Training
NCT04616261 ·Status: UNKNOWN ·Phase: NA
-
Dynamic Cardio-vascular, Cerebro-vascular and Cortical Interaction in Healthy Adult Subjects
NCT06785181 ·Status: RECRUITING ·Phase: NA
-
Study of Atomoxetine in the Prevention of Vasovagal Syncope
NCT05159687 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of Beta-blocker Therapy on QTc Response in Exercise and Recovery in Normal Subjects
NCT00588965 ·Status: COMPLETED ·Phase: NA
-
A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension
NCT01251146 ·Status: COMPLETED ·Phase: PHASE4
-
Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And Antagonist
NCT03070730 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Quality of Life After Hyperbaric Oxygen Therapy in Post-COVID Patients
NCT06159309 ·Status: ACTIVE_NOT_RECRUITING
-
POTS Adrenergic Ab (CIHR Aims #1&2)
NCT02673996 ·Status: RECRUITING
-
Clinical Assessment of Arterial Dynamic Elastance in ICU Patients, Dependent on Inotropic or Vasopressor Drugs.
NCT03621618 ·Status: WITHDRAWN ·Phase: NA
-
Hypnosis in Autonomic Function
NCT00061009 ·Status: COMPLETED
-
Metoprolol and Formoterol in Chronic Obstructive Pulmonary Disease (COPD)
NCT00288548 ·Status: UNKNOWN ·Phase: PHASE4
-
Domperidone and Risk of Serious Cardiac Events in Postpartum Women
NCT04024865 ·Status: COMPLETED
-
The Prognostic Role of Indices of Sympathetic Nervous System Overdrive in MINOCA
NCT04681612 ·Status: UNKNOWN
-
Autonomic Determinants of POTS - Pilot1
NCT04050410 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
The Effect of Beta-blocker on Chronotropic Response and Cardiorespiratory Fitness in Patients With Atrial Fibrillation
NCT05332457 ·Status: RECRUITING ·Phase: NA
-
The Influence of Beta Blocker Therapy on the Hemodynamic Response to Inotrope Infusion in Patients With Acute Decompensated Heart Failure
NCT01971944 ·Status: COMPLETED
-
Potential Impact of Neuroimmune and Autophagic Alterations on the Progression and Severity of Human Atherosclerotic Process
NCT03922698 ·Status: UNKNOWN